In addition, pretreatment of HCC cells with ADCM also expression of liver CSC markers, including CD47 and CD90 (Figure 1D); migration and invasion (Figure 1E); and resistance to doxorubicin and sorafenib (Figure 1F). This evidence concerns the gene THY1 and hepatocellular carcinoma.